Lig4,也称为DNA连接酶IV,是DNA损伤修复中非同源末端连接(NHEJ)途径的关键酶。NHEJ途径负责修复DNA双链断裂,这种断裂可能是由于DNA复制过程中的错误、化学物质或辐射造成的损伤。Lig4在NHEJ途径中执行最终的DNA断裂封口步骤,对于维持基因组稳定性和防止突变至关重要。此外,Lig4还参与V(D)J重组,这是T和B细胞发育中至关重要的重新连接过程。
Lig4基因的突变会导致Lig4综合征,这是一种罕见的遗传疾病,其特征包括免疫缺陷、对电离辐射的敏感性、宫内生长迟缓、出生后生长迟缓和小头畸形。Lig4基因的突变会导致DNA连接酶IV功能受损,进而影响V(D)J重组和DNA损伤修复,从而导致免疫缺陷和易患癌症。研究表明,Lig4基因的单等位基因突变可能导致免疫缺陷和自身免疫性疾病,这表明Lig4在免疫系统的正常功能中发挥着重要作用。
Lig4基因的多态性与癌症易感性之间的关系一直存在争议。一些研究表明,Lig4基因的某些多态性可能与癌症易感性相关,而其他研究则未发现这种关联。例如,一项meta分析研究了Lig4基因多态性与乳腺癌风险之间的关系,发现Lig4基因多态性与乳腺癌风险之间没有关联。然而,另一项meta分析表明,Lig4 T9I基因多态性在白种人中与癌症风险略有下降相关,而rs1805386基因多态性与癌症风险没有显著关联。
Lig4在癌症治疗中的应用也备受关注。例如,一项研究表明,抑制Lig4可以增强CRISPR-Cas9介导的基因编辑效率,这为精确基因治疗提供了新的思路。此外,另一项研究表明,Lig4介导的Wnt信号通路诱导的放射抗性,这为癌症治疗提供了新的靶点。
综上所述,Lig4在DNA损伤修复、免疫系统功能和癌症发生中发挥着重要作用。Lig4基因的突变和基因多态性与多种疾病相关,包括Lig4综合征、免疫缺陷和癌症。深入研究Lig4的生物学功能和分子机制,有助于开发新的治疗方法,并为疾病的治疗和预防提供新的思路和策略[1,2,3,4,5,6,7,8,9,10]。
参考文献:
1. Zhou, Li-Ping, Luan, Hong, Dong, Xi-Hua, Man, Dong-Liang, Shang, Hong. . Lack of association between LIG4 gene polymorphisms and the risk of breast cancer: a HuGE review and meta-analysis. In Asian Pacific journal of cancer prevention : APJCP, 13, 3417-22. doi:. https://pubmed.ncbi.nlm.nih.gov/22994770/
2. Chu, Van Trung, Weber, Timm, Wefers, Benedikt, Rajewsky, Klaus, Kühn, Ralf. 2015. Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. In Nature biotechnology, 33, 543-8. doi:10.1038/nbt.3198. https://pubmed.ncbi.nlm.nih.gov/25803306/
3. Singh, Amit, Senapati, Sabyasachi, Panigrahi, Inusha, Khetarpal, Preeti. 2024. Novel Compound Heterozygous Mutations of LIG4 Gene in an Indian LIG4 Syndrome Patient with Severe Microcephaly: Case Report, In-silico Analysis and Systematic Review. In Current pediatric reviews, , . doi:10.2174/0115733963285549240328083623. https://pubmed.ncbi.nlm.nih.gov/38591195/
4. Yue, T, Li, J G, Zhou, Z X, Liu, R, Shi, X D. . [LIG4 syndrome: a report of four cases and literature review]. In Zhonghua er ke za zhi = Chinese journal of pediatrics, 57, 217-221. doi:10.3760/cma.j.issn.0578-1310.2019.03.012. https://pubmed.ncbi.nlm.nih.gov/30818900/
5. Xie, Shang, Shan, Xiao-Feng, Shang, Kun, He, Jing, Cai, Zhi-Gang. 2014. Relevance of LIG4 gene polymorphisms with cancer susceptibility: evidence from a meta-analysis. In Scientific reports, 4, 6630. doi:10.1038/srep06630. https://pubmed.ncbi.nlm.nih.gov/25314918/
6. Chistiakov, Dimitry A. . Ligase IV syndrome. In Advances in experimental medicine and biology, 685, 175-85. doi:. https://pubmed.ncbi.nlm.nih.gov/20687505/
7. Su, Youle, Qi, Songtao, Dou, Changwu, Shuang, Lian, Yan, Haicheng. 2015. Association of LIG4 and XRCC4 gene polymorphisms with the risk of human glioma in a Chinese population. In International journal of clinical and experimental pathology, 8, 2057-62. doi:. https://pubmed.ncbi.nlm.nih.gov/25973104/
8. Bluteau, Olivier, Sebert, Marie, Leblanc, Thierry, Socié, Gérard, Soulier, Jean. 2017. A landscape of germ line mutations in a cohort of inherited bone marrow failure patients. In Blood, 131, 717-732. doi:10.1182/blood-2017-09-806489. https://pubmed.ncbi.nlm.nih.gov/29146883/
9. Jauch, Annaïse J, Bignucolo, Olivier, Seki, Sayuri, Yamamoto, Hiroyuki, Recher, Mike. 2023. Autoimmunity and immunodeficiency associated with monoallelic LIG4 mutations via haploinsufficiency. In The Journal of allergy and clinical immunology, 152, 500-516. doi:10.1016/j.jaci.2023.03.022. https://pubmed.ncbi.nlm.nih.gov/37004747/
10. Jun, Sohee, Jung, Youn-Sang, Suh, Han Na, Chen, Junjie, Park, Jae-Il. 2016. LIG4 mediates Wnt signalling-induced radioresistance. In Nature communications, 7, 10994. doi:10.1038/ncomms10994. https://pubmed.ncbi.nlm.nih.gov/27009971/